Sanofi to buy Genzyme for $20.1 billion | Latest News India - Hindustan Times
close_game
close_game

Sanofi to buy Genzyme for $20.1 billion

Hindustan Times | ByReuters, Paris
Feb 17, 2011 12:51 AM IST

French drug maker Sanofi-Aventis SA on Wednesday agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the US biotech group’s drugs, the companies said on Wednesday.

French drug maker Sanofi-Aventis SA on Wednesday agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the US biotech group’s drugs, the companies said on Wednesday.

HT Image
HT Image

Sanofi will pay $74 a share in cash and offer a tradable contingent value right, or CVR, whose value will depend on Genzyme’s experimental multiple sclerosis drug Lemtrada and production of two other medicines.

Hindustan Times - your fastest source for breaking news! Read now.

The deal’s announcemen marks the second-biggest in biotech history and will help Sanofi offset declining revenue from drugs that have lost, or are set to lose, patent protection.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On